Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Neuropace

Clinical trials sponsored by Neuropace, explained in plain language.

NeuroPace NPCE NASDAQ

NeuroPace makes an implantable brain-responsive neurostimulation device for epilepsy.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 2

Brain implant shows promise for Hard-to-Treat seizures in rare epilepsy

Disease control Ongoing

This study tests a brain-responsive neurostimulation system in 24 people aged 12 and older with Lennox-Gastaut syndrome whose seizures are not controlled by medication. The device detects and responds to seizure activity in the brain to reduce drop seizures. The goal is to see if…

Phase: PHASE2 • Sponsor: NeuroPace • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC